{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:44:02Z","timestamp":1792802642852,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis (OA) is a common chronic degenerative joint disease. At present, there is no effective treatment to check the progression of osteoarthritis. Osteochondral units are considered to be one of the most important structures affecting the occurrence and development of osteoarthritis. Osteoclasts mediate an increase in abnormal bone remodeling in subchondral bone in the early stage of osteoarthritis. Here, alendronate (ALN) that inhibit osteoclasts was used to study the regulatory effect of osteoclast-derived leukemia inhibitory factor (LIF) on early abnormal bone remodeling.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study involved 10-week-old wild-type female C57BL\/6 mice and female <jats:italic>SOST<\/jats:italic> knockout (KO) mice that were divided into the sham, vehicle, ALN, and <jats:italic>SOST<\/jats:italic> KO groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression of LIF was found to decrease by inhibiting osteoclasts, and the histological OA score suggested that the degeneration of articular cartilage was attenuated. Additionally, micro-CT showed that osteoclasts inhibited in the early stage of OA could maintain the microstructure of the subchondral bone. The parameters of bone volume fraction (BV\/TV), subchondral bone plate thickness (SBP.Th), and trabecular separation (Tb.Sp) of the treated group were better than those of the vehicle group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results suggested that downregulating the expression of sclerostin in osteocytes by secreting LIF from osteoclasts, activate the Wnt\/\u03b2-catenin signaling pathway, and promote abnormal bone remodeling in OA. Therefore, clastokine LIF might be a potential molecular target to promote abnormal bone remodeling in early OA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04886-2","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T20:02:36Z","timestamp":1643140956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Osteoclasts secrete leukemia inhibitory factor to promote abnormal bone remodeling of subchondral bone in osteoarthritis"],"prefix":"10.1186","volume":"23","author":[{"given":"Xin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunhua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"4886_CR1","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s11136-020-02502-9","volume":"29","author":"Y Xie","year":"2020","unstructured":"Xie Y, Yu Y, Wang JX, et al. Health-related quality of life and its influencing factors in Chinese with knee osteoarthritis. Qual Life Res. 2020;29:2395\u2013402.","journal-title":"Qual Life Res"},{"issue":"1","key":"4886_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.apmr.2020.04.001","volume":"102","author":"J Lo","year":"2020","unstructured":"Lo J, Chan L, Flynn S. A Systematic Review of the Incidence, Prevalence, Costs, and Activity and Work Limitations of Amputation, Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis, Spinal Cord Injury, Stroke, and Traumatic Brain Injury in the United States: A 2019 Update. Arch Phys Med Rehabil. 2020;102(1):115\u201331.","journal-title":"Arch Phys Med Rehabil"},{"key":"4886_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pbiomolbio.2017.12.004","volume":"148","author":"A Weber","year":"2019","unstructured":"Weber A, Chan PMB, Wen C. Do immune cells lead the way in subchondral bone disturbance in osteoarthritis? Prog Biophys Mol Biol. 2019;148:21\u201331.","journal-title":"Prog Biophys Mol Biol"},{"key":"4886_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1302\/2058-5241.4.180102","volume":"4","author":"S Donell","year":"2019","unstructured":"Donell S. Subchondral bone remodelling in osteoarthritis. EFORT Open Rev. 2019;4:221\u20139.","journal-title":"EFORT Open Rev"},{"key":"4886_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrrheum.2012.130","volume":"8","author":"DB Burr","year":"2012","unstructured":"Burr DB, Gallant MA. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012;8:665\u201373.","journal-title":"Nat Rev Rheumatol"},{"key":"4886_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1210\/er.2012-1026","volume":"34","author":"SL Dallas","year":"2013","unstructured":"Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell ... and more. Endocr Rev. 2013;34:658\u201390.","journal-title":"Endocr Rev"},{"key":"4886_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11914-017-0381-0","volume":"15","author":"T Ono","year":"2017","unstructured":"Ono T, Takayanagi H. Osteoimmunology in bone fracture healing. Curr Osteoporos Rep. 2017;15:367\u201375.","journal-title":"Curr Osteoporos Rep"},{"key":"4886_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/jbmr.1485","volume":"27","author":"IJ Poulton","year":"2012","unstructured":"Poulton IJ, McGregor NE, Pompolo S, Walker EC, Sims NA. Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization. J Bone Miner Res. 2012;27:586\u201395.","journal-title":"J Bone Miner Res"},{"key":"4886_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1006\/cyto.2002.2002","volume":"20","author":"E Grimaud","year":"2002","unstructured":"Grimaud E, Blanchard F, Charrier C, Gouin F, Redini F, Heymann D. Leukaemia inhibitory factor (lif) is expressed in hypertrophic chondrocytes and vascular sprouts during osteogenesis. Cytokine. 2002;20:224\u201330.","journal-title":"Cytokine"},{"key":"4886_CR10","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/jbmr.3175","volume":"32","author":"M Koide","year":"2017","unstructured":"Koide M, Kobayashi Y, Yamashita T, et al. Bone formation is coupled to resorption via suppression of Sclerostin expression by osteoclasts. J Bone Miner Res. 2017;32:2074\u201386.","journal-title":"J Bone Miner Res"},{"key":"4886_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","volume":"96","author":"MM Weivoda","year":"2017","unstructured":"Weivoda MM, Youssef SJ, Oursler MJ. Sclerostin expression and functions beyond the osteocyte. Bone. 2017;96:45\u201350.","journal-title":"Bone"},{"key":"4886_CR12","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1038\/s41467-019-10439-y","volume":"10","author":"JC Klein","year":"2019","unstructured":"Klein JC, Keith A, Rice SJ, et al. Functional testing of thousands of osteoarthritis-associated variants for regulatory activity. Nat Commun. 2019;10:2434.","journal-title":"Nat Commun"},{"key":"4886_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/0022034513500306","volume":"92","author":"BF Boyce","year":"2013","unstructured":"Boyce BF. Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res. 2013;92:860\u20137.","journal-title":"J Dent Res"},{"key":"4886_CR14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bone.2009.03.671","volume":"44","author":"K Henriksen","year":"2009","unstructured":"Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA. Local communication on and within bone controls bone remodeling. Bone. 2009;44:1026\u201333.","journal-title":"Bone"},{"key":"4886_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13075-015-0546-0","volume":"17","author":"MS Khorasani","year":"2015","unstructured":"Khorasani MS, Diko S, Hsia AW, et al. Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice. Arthritis Res Ther. 2015;17:30.","journal-title":"Arthritis Res Ther"},{"key":"4886_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.joca.2010.01.004","volume":"18","author":"F Intema","year":"2010","unstructured":"Intema F, Hazewinkel HA, Gouwens D, et al. In early OA, thinning of the subchondral plate is directly related to cartilage damage: results from a canine ACLT-meniscectomy model. Osteoarthr Cartil. 2010;18:691\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"4886_CR17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.joca.2008.02.018","volume":"16","author":"RI Bolbos","year":"2008","unstructured":"Bolbos RI, Zuo J, Banerjee S, et al. Relationship between trabecular bone structure and articular cartilage morphology and relaxation times in early OA of the knee joint using parallel MRI at 3 T. Osteoarthr Cartil. 2008;16:1150\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"4886_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/art.24824","volume":"61","author":"T Neogi","year":"2009","unstructured":"Neogi T, Felson D, Niu J, et al. Cartilage loss occurs in the same subregions as subchondral bone attrition: a within-knee subregion-matched approach from the multicenter osteoarthritis study. Arthritis Rheum. 2009;61:1539\u201344.","journal-title":"Arthritis Rheum"},{"key":"4886_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1172\/JCI10564","volume":"107","author":"LA Neuhold","year":"2001","unstructured":"Neuhold LA, Killar L, Zhao W, et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest. 2001;107:35\u201344.","journal-title":"J Clin Invest"},{"key":"4886_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/art.1780350715","volume":"35","author":"K von der Mark","year":"1992","unstructured":"von der Mark K, Kirsch T, Nerlich A, et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum. 1992;35:806\u201311.","journal-title":"Arthritis Rheum"},{"key":"4886_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nm.1979","volume":"15","author":"Y Tang","year":"2009","unstructured":"Tang Y, Wu X, Lei W, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15:757\u201365.","journal-title":"Nat Med"},{"key":"4886_CR22","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nm.2793","volume":"18","author":"L Xian","year":"2012","unstructured":"Xian L, Wu X, Pang L, et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med. 2012;18:1095\u2013101.","journal-title":"Nat Med"},{"key":"4886_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bone.2013.07.023","volume":"57","author":"K Ota","year":"2013","unstructured":"Ota K, Quint P, Weivoda MM, et al. Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors. Bone. 2013;57:68\u201375.","journal-title":"Bone"},{"key":"4886_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1097-2765(03)00365-4","volume":"12","author":"MJ Boulanger","year":"2003","unstructured":"Boulanger MJ, Bankovich AJ, Kortemme T, Baker D, Garcia KC. Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol Cell. 2003;12:577\u201389.","journal-title":"Mol Cell"},{"key":"4886_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1172\/JCI40568","volume":"120","author":"EC Walker","year":"2010","unstructured":"Walker EC, McGregor NE, Poulton IJ, et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest. 2010;120:582\u201392.","journal-title":"J Clin Invest"},{"key":"4886_CR26","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1359\/jbmr.060810","volume":"21","author":"DL Ellies","year":"2006","unstructured":"Ellies DL, Viviano B, McCarthy J, et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res. 2006;21:1738\u201349.","journal-title":"J Bone Miner Res"},{"key":"4886_CR27","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3892\/ijmm.2016.2741","volume":"38","author":"L Wu","year":"2016","unstructured":"Wu L, Guo H, Sun K, Zhao X, Ma T, Jin Q. Sclerostin expression in the subchondral bone of patients with knee osteoarthritis. Int J Mol Med. 2016;38:1395\u2013402.","journal-title":"Int J Mol Med"},{"key":"4886_CR28","first-page":"7623562","volume":"2019","author":"J Li","year":"2019","unstructured":"Li J, Xue J, Jing Y, et al. SOST deficiency aggravates osteoarthritis in mice by promoting sclerosis of subchondral bone. Biomed Res Int. 2019;2019:7623562.","journal-title":"Biomed Res Int"},{"key":"4886_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.22203\/eCM.v030a19","volume":"30","author":"LE Mulcahy","year":"2015","unstructured":"Mulcahy LE, Curtin CM, McCoy RJ, et al. The effect of bisphosphonate treatment on the biochemical and cellular events during bone remodelling in response to microinjury stimulation. Eur Cell Mater. 2015;30:271\u201381.","journal-title":"Eur Cell Mater"},{"key":"4886_CR30","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/jor.20145","volume":"24","author":"JA Spadaro","year":"2006","unstructured":"Spadaro JA, Damron TA, Horton JA, et al. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge. J Orthop Res. 2006;24:936\u201344.","journal-title":"J Orthop Res"},{"key":"4886_CR31","first-page":"475","volume":"5","author":"IJ Diel","year":"2007","unstructured":"Diel IJ, Bergner R, Grotz KA. Adverse effects of bisphosphonates: current issues. J Support Oncol. 2007;5:475\u201382.","journal-title":"J Support Oncol"},{"key":"4886_CR32","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1152\/japplphysiol.00978.2011","volume":"112","author":"BR Macias","year":"2012","unstructured":"Macias BR, Swift JM, Nilsson MI, Hogan HA, Bouse SD, Bloomfield SA. Simulated resistance training, but not alendronate, increases cortical bone formation and suppresses sclerostin during disuse. J Appl Physiol. 2012;112:918\u201325.","journal-title":"J Appl Physiol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04886-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04886-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04886-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T20:03:37Z","timestamp":1643141017000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04886-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4886"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04886-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"8 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures were carried out in accordance with the National Institutes of Health Guide for the care and Use of Laboratory Animals, and were approved by the medical research ethics committee of the General Hospital of Ningxia Medical University (Yinchuan, China) (protocol No. 2018\u2013056).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflict of interest was reported by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}